Xin Lang Cai Jing·2025-10-09 02:30Core Viewpoint - 凯莱英's stock price has shown significant growth this year, with a year-to-date increase of 48.57%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the first half of 2025, 凯莱英 reported revenue of 3.188 billion yuan, representing a year-on-year growth of 18.20%, and a net profit attributable to shareholders of 617 million yuan, up 23.71% [2]. - CMO services account for 76.19% of 凯莱英's main business revenue, while emerging services contribute 23.71% [1]. Stock Market Activity - As of October 9, 凯莱英's stock price was 111.42 yuan per share, with a market capitalization of 40.177 billion yuan [1]. - The stock has experienced a net outflow of 21.6685 million yuan in principal funds, with significant trading activity reflected in the buying and selling volumes [1]. Shareholder Information - As of June 30, 2025, 凯莱英 had 41,300 shareholders, a decrease of 5.16% from the previous period [2]. - The top ten circulating shareholders include notable funds, with 中欧医疗健康混合A holding 16.2843 million shares, a decrease of 27,500 shares from the previous period [3].